Nanjing Xingyin Pharmaceutical Group Co., Ltd. was established by Shenzhen Xingyin Pharmaceutical Co., Ltd. in September 2001 in Lishui, a new pharmaceutical enterprise focusing on the research and development, production and sales of western medicine, raw materials and medical and health products. It has won many honorary titles such as "Jiangsu High-tech Enterprise", "Nanjing Honest Labor Security Enterprise" and "Construction of New Lishui Meritorious Unit".
The company covers an area of 250 mu, of which the preparation base covers an area of 110 mu, and the living area matching with the preparation base covers an area of 140 mu. The company has more than 240 employees and more than 30 management personnel. In March 2009, Nanjing Xingyin Pharmaceutical Co., Ltd. was approved to set up a group company, which owns eight subsidiaries including Nanjing Xingyin Pharmaceutical Research Co., LTD., Shenzhen Jianyuan Pharmaceutical Technology Co., LTD., Nanjing Yinda Pharmaceutical Co., LTD., forming a modern pharmaceutical enterprise with a certain asset scale, a certain competitiveness, and a certain ability to resist risks.
The company has built six production workshops, including lyophilized powder injection, oral liquid preparation (mixture, oral solution), spray, solid preparation, traditional Chinese medicine extraction and peptide workshop, with international advanced instruments and equipment, production technical facilities, testing and professional personnel, and has strong technical force, scientific management system and sound and stable national marketing network. And in line with the international market. The company operates in strict accordance with GMP and has established a set of perfect quality assurance system. At present, the company mainly produces Gegen Tang mixture, Xingrelin nasal spray for treating cold, Codeine phosphate compound for cough, adenosine cyclophosphate for injection, Pefloxacin mesylate for injection, compound naphthozoline spray, triamcinolone olone nasal spray, Zareplon tablets, etc.
The company has been adhering to the "medicine for the people" business mission, adhere to the "people-oriented" strategic policy, to science and technology as the leader, to sales as the driving force, relying on good reputation, high-quality quality, reliable curative effect, first-class management and service to win the market, and always with the ambition of industry to serve the country and the heart of a hundred years of Xingyin.